Members of the European Parliament recommended: Take medical use of cannabis seriously

Members of the European Parliament (MEP) proposed the ways to address research gaps on medical cannabis and call on member states to seize the potential of cannabis-based medicines.

In a resolution adopted on Wednesday 11 September, MEPs call on the Commission and national authorities to draw a clear distinction between medical cannabis and other uses of cannabis. The resolution urges the Commission and member states to address regulatory, financial and cultural barriers which burden scientific research and invites them to properly fund research. The EU should embark on more research and stimulate innovation with regard to medicinal cannabis projects.

MEPs call on member states to allow doctors to use their professional judgement in prescribing cannabis-based medicines. When effective, these medicines are to be covered by health insurance schemes in the same way as other types of medicine, they say.

European Parliament

The regulation of cannabis-based medicines would translate into additional revenue for public authorities, would limit the black market and ensure quality and accurate labelling. It would also limit minors’ access to this substance, they say.

MEPs say that there is evidence that cannabis or cannabinoids may be effective in increasing appetite and decreasing weight loss associated with HIV/AIDS. Medical cannabis may also help to alleviate the symptoms of mental disorders such as psychosis or Tourette syndrome, and to alleviate the symptoms of epilepsy, as well as Alzheimer’s, arthritis, asthma, cancer, Crohn’s disease and glaucoma. They also help to reduce the risk of obesity and diabetes and ease menstrual pain.

Whilst the WHO has officially recommended that the cannabis compound cannabidiol (CBD) should not be classified as a controlled substance, legislation in member states differs widely on the subject of cannabis for medicinal purposes.

The European Parliament is made up of 751 Members elected in the 28 Member States of the enlarged European Union. Since 1979 MEPs have been elected by direct universal suffrage for a five-year period.

Pride Week in Belgrade started

Belgrade Pride Week 2019 has begun on Monday 9th and will end with the Belgrade Pride, which will be held on Sunday 15th September.

The opening ceremony was held at the City of Belgrade’s National Assembly. Jovanka Todorović, representing the Organizational board of Belgrade Pride, opened this year’s Pride Week and gave an overview of all the important events that will take place. Goran Miletić and Marko Mihailović, fellow members of the Organizational board, spoke about the political messages of the “I do not renounce” campaign, as well as Belgrade’s candidature to host EuroPride in 2022.

Pride Week: Grand Opening

During this week Belgrade Pride will organize workshops, open talks with the community, exhibitions, movies projections, performances as well as the first Belgrade Pride Theater Festival. This year the face of the Pride is singer Sara Jovanović.

Also, the Pride Info Center with our associate member association Duga (Rainbow), will provide free HIV testing, every day during Pride Week from 3pm to 6pm, in Kralja Milana 20 in Belgrade.

The Pride walk will begin on Sunday at 5 pm on Slavija Square.

The plan and program of events during the Pride Week 2019 and plan of  Pride Walk is available following link>>>

 

5th Cannabis International Seminar

Research Nature Institute organizes 5th seminar in the Demystifying Cannabis cycle, Cannabis Now International Conference on October the 4th and 5th in Ljubljana, Slovenia. The seminar has been organised since 2014 in Ljubljana, Belgrade, Skopje and Zagreb.

During the seminar, the Slovenian and international top-level experts on cannabis will introduce us to the most recent insights into the medical use of cannabis in different countries around the world (Israel, Canada, USA, the Czech Republic, Spain). After their lecture, they will respond to your questions in a debate. The attenders and speakers at the Conference are experts in field of medicine, psychiatry, pharmacy, chemistry and biology: Dr. Jonathan Grunfeld, Dr. Lumír Ondřej Hanuš, Prof. Dr. David Neubauer, Dr. Sue Sisley, Doc. dr. Tanja Bagar, Dr. Dorothy H. Bray, Dr. Guillermo Velasco Díez, Dr. Paul Hornby, Prof. Dr. Tamara Lah Turnšek, Mag. Dušan Nolimal, Dr. Ilya Reznik, Dr. Roman Štukelj.

Research Nature Institute

Research Nature Institute is institute for research, development and quality assurance of nature remedies, with the goal to research the efficacy and safety of natural remedies that are currently available or are of limited access to persons in need. By setting standards for quality control and standardization, providing accreditation programs, and taking part in clinical trials, their aim is to ensure natural remedies are clean (free of contaminants) and effective at known dosages to the user. Their basic work is to educate the public, medical professionals and legislators of our findings based on sound scientific methodologies and principles.

To read more details about this event follow this link>>>

A large European survey among men who have sex with men

The European Men-Who-Have-Sex-With-Men Internet Survey EMIS-2017 collected comparable data from 127.792 participants – men who have sex with men from 48 countries in Europe. It provides insights on their knowledge of HIV, viral hepatitis and sexually transmitted infections (STI), sexual behaviour, prevention needs and testing habits.

EMIS-2017 was executed by Sigma Research (London School of Hygiene and Tropical Medicine) as part of European Surveys and Training to Improve MSM Community Health (ESTICOM). It was a three-year project (2016-2019) funded by the European Commission Health Programme 2014-2020 through a tender by the Consumers, Health, Agriculture and Food Executive Agency (Chafea).

The results show considerable differences across the countries reflecting Europe’s diversity with respect to sexual health and behaviour of MSM. The report describes both MSM behaviour and needs, alongside resulting morbidities, and the likely value of current services to address these.

The Executive Summary indicates that sex between men remains the predominant mode of HIV transmission in the EU/EEA countries, where the first signs of a decline in reported new cases resulted from a 20% drop in new diagnoses among MSM (2015-2017). Responses to a survey that focused on knowledge about HIV and sexually transmitted infections, sexual behaviour, access to care, HIV-related stigma and the use of services for HIV and sexual health is a strong indication that this group cares about HIV and sexual health issues. For example, every second (56%) respondent had received an HIV test result in the last 12 months and almost half (46%) had tested for other STI during the same period.

To read full Report, follow this link>>>